Boston Commerce board to consider share capital reduction

Boston Commerce Limited has scheduled a meeting of its Board of Directors on Friday, June 05, 2026, to consider a proposal for the reduction of the company's share capital. The agenda includes seeking necessary approvals, consents, and sanctions as required under the applicable provisions of the Companies Act, 2013, and other relevant laws. The meeting will also cover any other matter with the permission of the Chair.

Meeting Details

The Board meeting will be convened pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The primary focus of the meeting is to evaluate and potentially approve the capital reduction plan.

Agenda Item	Description
Share Capital Reduction	Proposal to reduce the share capital subject to statutory approvals
Other Business	Any other matter with the permission of the Chair

The company, formerly known as Boston Bio Systems Limited, is registered at A.828, Sun West Bank, Ashram Road P.O, Ahmedabad, Gujarat. The intimation was submitted by Ghanshyam Dhananjay Gavali, Managing Director.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.94%	-5.10%	+6.96%	-2.75%	-0.70%	-66.17%

Boston Commerce Limited reported a net loss of ₹58.08 lakh for the financial year ended March 31, 2026, compared to a net loss of ₹54.73 lakh in the previous year. The company recorded zero revenue from operations for the quarter ended March 31, 2026, while total revenue for the full fiscal year stood at ₹48.37 lakh. The Board of Directors approved the audited standalone financial results at a meeting held on May 30, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The statutory auditors, M/s. Sunit M Chhatbar & Co, issued an audit report with an unmodified opinion on the standalone financial results. However, the auditors noted that the company did not make any payment of Tax Deducted at Source (TDS) dues during the financial year 2025-26 as required under the applicable provisions of the Income-tax Act, 1961. The meeting, which commenced at 3:00 p.m. and concluded at 5:15 p.m., was held at the company's registered office in Ahmedabad.

Financial Performance Summary

The company's financial performance for the quarter and year ended March 31, 2026, reflects a challenging period with no operational income in the final quarter. Finance costs for the year amounted to ₹15.42 lakh, while depreciation and amortisation expenses were recorded at ₹59.23 lakh. Exceptional items for the year totaled ₹58.08 lakh. The basic and diluted earnings per share (EPS) for the year stood at a loss of ₹0.83, compared to a loss of ₹0.78 in the previous year.

Metric	Q4 FY26 (₹ in lakhs)	FY26 (₹ in lakhs)	FY25 (₹ in lakhs)
Revenue from operations	-	48.37	19.25
Total expenses	4.55	31.79	73.98
Profit / (Loss) before tax	-	-	-
Net Profit / (Loss)	(64.58)	(58.08)	(54.73)
Basic EPS (Rs.)	(0.92)	(0.83)	(0.78)

Assets and Liabilities

The total assets of the company decreased to ₹892.61 lakh as of March 31, 2026, from ₹2,387.34 lakh in the previous year. Total shareholders' funds stood at ₹532.38 lakh, a decrease from ₹590.45 lakh in the prior year. Current liabilities reduced to ₹204.12 lakh from ₹440.62 lakh, while non-current liabilities were nil at the end of FY26 compared to ₹459.29 lakh in FY25. Cash and cash equivalents at the end of the year were ₹8.70 lakh.